The emerging approach of this peptide represents a significant advance in the handling of type 2 diabetes. Unlike existing medications, tirzepatide targets two pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatidepeptide641671.dsiblogger.com/75206051/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment